CU-Led Project Targets Osteoarthritis Reversal, Human Trials by 2028
Christopher.Casey@ucdenver.edu (Chris Casey)
A groundbreaking and fast-paced effort – combining biologic, clinical and regulatory expertise at the University of Colorado Anschutz – has helped propel an ambitious nationwide attempt to reverse osteoarthritis (OA), a painful degenerative disease that affects 32 million Americans.